Although cytoplasmic AMP-activated protein kinase (AMPK) has been known as a tumor-suppressor protein, nuclear AMPK is suggested to support clear cell renal cell carcinoma (ccRCC). This evidence concerns the gene PRKAA2 and nonpapillary renal cell carcinoma.